The Investigation of MAPK7 Gene Variations in Colorectal Cancer Risk

Background/Aim: Mitogen-activated protein kinases (MAPKs) are important regulatory molecules, which have essential roles in physiology and pathology. In the present study, we examined the possible correlation between the MAPK7 gene and colorectal cancer risk in the Turkish population. Materials and Methods: A total of 100 human DNA samples (50 colorectal cancer patients and 50 healthy individuals) were sequenced using next-generation sequencing to define the potential genetic variations in the MAPK7 gene. Results: Five genetic variations (MAPK7; rs2233072, rs2233076, rs181138364, rs34984998, rs148989290) were detected in our study group. The G (variant) allele of the MAPK7; rs2233072 (T>G) gene polymorphism was found in 76% of colorectal cancer cases, and 66% of controls. The prevalence of rs2233076, rs181138364, rs34984998, and rs148989290 gene variations was quite rare in the subjects and no significant association in terms of genotype and allele frequencies was observed between the cases and controls. Conclusion: No statistically significant correlation between the MAP7 kinase gene variations and colorectal cancer risk was observed. This is the first investigation in the Turkish population that may initiate additional studies in larger populations to analyze the effect of MAPK7 gene on the colorectal cancer risk.

[1]  C. Ghigna,et al.  Clinical Significance and Regulation of ERK5 Expression and Function in Cancer , 2022, Cancers.

[2]  S. Cook,et al.  Small molecule ERK5 kinase inhibitors paradoxically activate ERK5 signalling: be careful what you wish for… , 2020, Biochemical Society transactions.

[3]  Jun Yu,et al.  Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors , 2019, International journal of molecular sciences.

[4]  Fanhua Kong,et al.  MiR-143-3p inhibits the proliferation, cell migration and invasion of human breast cancer cells by modulating the expression of MAPK7. , 2018, Biochimie.

[5]  Jie Chen,et al.  Role of MAPK7 in cell proliferation and metastasis in ovarian cancer. , 2015, International journal of clinical and experimental pathology.

[6]  P. Delrio,et al.  Genetics, diagnosis and management of colorectal cancer (Review) , 2015, Oncology reports.

[7]  K. Khanna,et al.  MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments , 2015, Oncoscience.

[8]  R. Ramesh,et al.  Mitogen-activated protein kinases and their role in radiation response. , 2013, Genes & cancer.

[9]  Martha L Slattery,et al.  MAP kinase genes and colon and rectal cancer. , 2012, Carcinogenesis.

[10]  Y. Juliano,et al.  MAPK7 and MAP2K4 as prognostic markers in osteosarcoma. , 2012, Human pathology.

[11]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[12]  Michael Krawczak,et al.  Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. , 2010, Carcinogenesis.

[13]  M. Pino,et al.  The chromosomal instability pathway in colon cancer. , 2010, Gastroenterology.

[14]  K. Pavelić,et al.  Integrated gene networks in breast cancer development , 2010, Functional & Integrative Genomics.

[15]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[16]  M. Bertagnolli,et al.  Molecular origins of cancer: Molecular basis of colorectal cancer. , 2009, The New England journal of medicine.

[17]  J. Montero,et al.  Expression of Erk5 in Early Stage Breast Cancer and Association with Disease Free Survival Identifies this Kinase as a Potential Therapeutic Target , 2009, PloS one.

[18]  M. Taniwaki,et al.  ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry , 2009, Genes, chromosomes & cancer.

[19]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[20]  Pierre Laurent-Puig,et al.  Mutations in the RAS‐MAPK, PI(3)K (phosphatidylinositol‐3‐OH kinase) signaling network correlate with poor survival in a population‐based series of colon cancers , 2008, International journal of cancer.

[21]  Philip R. Cohen,et al.  Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer , 2008, Oncogene.

[22]  C. Tournier,et al.  Regulation of cellular functions by the ERK5 signalling pathway. , 2006, Cellular signalling.

[23]  S. Gruber,et al.  Genetics of colorectal cancer. , 2006, Oncology.

[24]  Y. Ho,et al.  Recent advances in the total management of colorectal cancer. , 2003, Annals of the Academy of Medicine, Singapore.

[25]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[26]  A. Winoto,et al.  ERK5 Is a Novel Type of Mitogen-Activated Protein Kinase Containing a Transcriptional Activation Domain , 2000, Molecular and Cellular Biology.

[27]  S. Knuutila,et al.  Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma. , 2002, Cancer genetics and cytogenetics.

[28]  RESEARCH ARTICLE Open Access Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer , 2022 .